Galera Therapeutics (GRTX) Gets a Hold From H.C. Wainwright
Citi Sticks to Its Hold Rating for Galera Therapeutics (GRTX)
Citigroup Maintains Neutral on Galera Therapeutics, Lowers Price Target to $0.25
Galera Therapeutics Analyst Ratings
Piper Sandler Remains a Hold on Galera Therapeutics (GRTX)
Galera Therapeutics Analyst Ratings
H.C. Wainwright Downgrades Galera Therapeutics (GRTX) to a Hold
Galera Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Decibel Therapeutics (DBTX), Galera Therapeutics (GRTX) and Sonendo (SONX)
Analysts Are Bullish on Top Healthcare Stocks: Galera Therapeutics (GRTX), Acumen Pharmaceuticals (ABOS)
Galera Therapeutics Analyst Ratings
Piper Sandler Remains a Buy on Galera Therapeutics (GRTX)
Analyst Ratings for Galera Therapeutics
HC Wainwright Adjusts Galera Therapeutics Price Target to $6 From $10, Maintains Buy Rating
HC Wainwright & Co. Maintains Buy on Galera Therapeutics, Lowers Price Target to $6
H.C. Wainwright Reaffirms Their Buy Rating on Galera Therapeutics (GRTX)
Galera Therapeutics (GRTX) Receives a Buy From BTIG
Piper Sandler Initiates Coverage On Galera Therapeutics With Overweight Rating, Announces Price Target of $6
Analysts Are Bullish on Top Healthcare Stocks: Vir Biotechnology (VIR), Galera Therapeutics (GRTX)
Analysts' Top Healthcare Picks: Urogen Pharma (URGN), Galera Therapeutics (GRTX)